miRl44-3p inhibits PMVECs excessive proliferation in angiogenesis of hepatopulmonary syndrome via Tie2
miRl44-3p inhibits PMVECs excessive proliferation in angiogenesis of hepatopulmonary syndrome via Tie2
复制标题
miRl44-3p通过Tie2抑制肝肺综合征血管生成中PMVEC过度增殖
DOI:
10.1016/j.yexcr.2018.02.009
复制
发表时间:
2018-04-01
影响因子:
3.7
通讯作者:
Lu, Kaizhi
中科院分区:
文献类型:
--
作者:
Yang, Congwen;Lv, Keyi;Lu, Kaizhi
Background/aim: Increasing evidence show microRNAs (miRNAs) are associated with hepatopulmonary syndrome (HPS). The aim of this study was to investigate the role of miR-144 in the angiogenesis of HPS, as well as to identify its underlying mechanism.Methods: The expression levels of miR-144-3p were assessed in pulmonary micro-vascular endothelial cells (PMVECs), as well as in lung tissues from rats with HPS. We predicted the potential target of miR-144-3p. Tyrosine kinase 2(Tie2) was identified as a target gene of miR144-3p, which has an essential role in the angiogenesis of lung vessel. In addition, the effects of miR-144-3p regulated on Tie2 was examined. The upregulation and down-regulation of miR-144-3p can affect the proliferation of PMVECs.Results: We found that the levels of miR-144-3p were frequently downregulated in HPS tissues and cell lines, and overexpression of miR-144-3p dramatically inhibited PMVECs proliferation and cell cycle. We further verified the Tie2 as a novel and direct target of miR-144-3p in HPS.Conclusion: miR-144-3p can negatively regulate PMVECs proliferation by Tie2 expression. In addition, over expression of miR-144-3p may prove beneficial as a therapeutic strategy for HPS treatment.